Residency · Bethesda, MD
Sponsored by National Capital Consortium
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
The New England journal of medicine · 2023 · 405 citations · John Moroney
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · John Moroney
Clinician Educator Milestones: Assessing and Improving Educators' Skills.
Academic medicine : journal of the Association of American Medical Colleges · 2024 · 31 citations · Joseph Kaczmarczyk
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019.
Anesthesia and analgesia · 2021 · 238 citations · Amanda Jackson
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial.
The Lancet. Oncology · 2025 · 28 citations · John Moroney
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecologic oncology · 2022 · 71 citations ·
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2025 · 19 citations · William Zammarrelli
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 48 citations · William Zammarrelli